U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 63 books (252 items)

1.
Holland-Frei Cancer Medicine. 6th edition.

Holland-Frei Cancer Medicine. 6th edition.

Kufe DW, Pollock RE, Weichselbaum RR, et al., editors.

Hamilton (ON): BC Decker; 2003.

3.
Hormonal Contraception and Post-menopausal Hormonal Therapy.

Hormonal Contraception and Post-menopausal Hormonal Therapy.

IARC Working Group on the Evaluation of Carcinogenic Risks to Humans.

Lyon (FR): International Agency for Research on Cancer; 1999. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 72.)

4.
StatPearls [Internet].

StatPearls [Internet].

Treasure Island (FL): StatPearls Publishing; 2026 Jan-.

5.
6.
Cystic Fibrosis: Diagnosis and management.

Cystic Fibrosis: Diagnosis and management.

National Guideline Alliance (UK).

London: National Institute for Health and Care Excellence (NICE); 2017 Oct 25. (NICE Guideline, No. 78.)

7.
Combined Estrogen–Progestogen Contraceptives and Combined Estrogen–Progestogen Menopausal Therapy.

Combined Estrogen–Progestogen Contraceptives and Combined Estrogen–Progestogen Menopausal Therapy.

IARC Working Group on the Evaluation of Carcinogenic Risks to Humans.

Lyon (FR): International Agency for Research on Cancer; 2007. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 91.)

8.
Oral Contraceptives & Breast Cancer.

Oral Contraceptives & Breast Cancer.

Institute of Medicine (US) Committee on the Relationship Between Oral Contraceptives and Breast Cancer.

Washington (DC): National Academies Press (US); 1991.

9.
Endotext [Internet].

Endotext [Internet].

Feingold KR, Adler RA, Ahmed SF, et al., editors.

South Dartmouth (MA): MDText.com, Inc.; 2000-.

10.
Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs Volumes 1 to 42.

Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs Volumes 1 to 42.

IARC Working Group on the Evaluation of Carcinogenic Risks to Humans.

Lyon (FR): International Agency for Research on Cancer; 1987. (IARC MONOGRAPHS ON THE EVALUATION OF CARCINOGENIC RISKS TO HUMANS, No. Supplement 7.)

11.
Pharmaceuticals.

Pharmaceuticals.

IARC Working Group on the Evaluation of Carcinogenic Risks to Humans.

Lyon (FR): International Agency for Research on Cancer; 2012. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 100A.)

12.
Improving Palliative Care for Cancer.

Improving Palliative Care for Cancer.

Institute of Medicine (US) and National Research Council (US) National Cancer Policy Board; Foley KM, Gelband H, editors.

Washington (DC): National Academies Press (US); 2001.

13.
The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research.

The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research.

National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Population Health and Public Health Practice; Committee on the Health Effects of Marijuana: An Evidence Review and Research Agenda.

Washington (DC): National Academies Press (US); 2017 Jan 12.

18.
Rare Diseases and Orphan Products: Accelerating Research and Development.

Rare Diseases and Orphan Products: Accelerating Research and Development.

Institute of Medicine (US) Committee on Accelerating Rare Diseases Research and Orphan Product Development; Field MJ, Boat TF, editors.

Washington (DC): National Academies Press (US); 2010.

19.
Nutrition as Prevention for Improved Cancer Health Outcomes [Internet].

Nutrition as Prevention for Improved Cancer Health Outcomes [Internet].

Parsons HM, Forte ML, Abdi HI, et al.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2023 May. (Comparative Effectiveness Review, No. 260.)

20.
Evidence review for intractable nausea and vomiting: Cannabis-based medicinal products: Evidence review A.

Evidence review for intractable nausea and vomiting: Cannabis-based medicinal products: Evidence review A.

London: National Institute for Health and Care Excellence (NICE); 2019 Nov. (NICE Guideline, No. 144.)

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Images search in Bookshelf

Search details

See more...

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...